CIMDUO 300 mg/1
Lamivudine and Tenofovir Disoproxil Fumarate · TABLET, FILM COATED · Viatris Specialty LLC
CIMDUO is a tablet, film coated containing lamivudine and tenofovir disoproxil fumarate at 300 mg/1, taken oral. Manufactured by Viatris Specialty LLC.
Key Facts
- Brand Name
- CIMDUO
- Generic Name
- Lamivudine and Tenofovir Disoproxil Fumarate
- NDC Code (Product)
49502-450- Manufacturer
- Viatris Specialty LLC
- Strength
- 300 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA022141
- Drug Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 06/25/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is CIMDUO used for?
CIMDUO contains Lamivudine and Tenofovir Disoproxil Fumarate. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is CIMDUO a controlled substance?
CIMDUO is not classified as a controlled substance by the DEA.
What is the generic name for CIMDUO?
The generic name for CIMDUO is Lamivudine and Tenofovir Disoproxil Fumarate. There are no other listed brand versions of Lamivudine and Tenofovir Disoproxil Fumarate.
What is the NDC code for CIMDUO 300 mg/1?
The NDC (National Drug Code) for CIMDUO 300 mg/1 is 49502-450, listed by Viatris Specialty LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)